Heterocyclic aspartyl protease inhibitors

Details for Australian Patent Application No. 2005317204 (hide)

Owner Schering Corporation Pharmacopeia, Inc.

Inventors Voigt, Johannes H.; Iserloh, Ulrich; Tadesse, Dawit; Stamford, Andrew; Guo, Tao; Qian, Gang; Greenlee, William J.; Smith, Elizabeth M.; Le, Thuy X. H.; Gu, Huizhong; Wu, Yusheng; Strickland, Corey; Hunter, Rachael C.; Caldwell, John; Zhu, Zhaoning; Babu, Suresh D.; Ye, Yuanzan C.; Cumming, Jared; Saionz, Kurt W.; Wang, Lingyan; Sun, Zhong-Yue; Morris, Michelle L.; Mazzola, Robert; McKittrick, Brian

Agent Griffith Hack

Pub. Number AU-B-2005317204

PCT Pub. Number WO2006/065277

Priority 11/010,772 13.12.04 US

Filing date 9 June 2005

Wipo publication date 22 June 2006

Acceptance publication date 17 February 2011

International Classifications

C07D 233/46 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4168 (2006.01)

A61K 31/4178 (2006.01)

C07D 233/88 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 239/22 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 273/00 (2006.01) Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 407/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/065277 Priority application(s): WO2006/065277

17 February 2011 Application Accepted

  Published as AU-B-2005317204

16 June 2011 Standard Patent Sealed

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.; Pharmacopeia, Inc. 2006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005317224-Point of use cleaning solution

2005317202-Mesh network of intelligent devices communicating via powerline and radio frequency